Refreshing the biologic pipeline 2020.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33510484.
- Also identified by DOI 10.1038/s41587-021-00814-w and PMC identifier 7842168.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the absence of face-to-face meetings, FDA and industry implemented regulatory workarounds to maintain drug and biologics approvals. These could be here to stay.
Medical subject headings
- Biological Products